Skip to main content
. 2015 Feb 4;2015(2):CD003130. doi: 10.1002/14651858.CD003130.pub3
General information Instructions Data extracted
First author    
Sponsorship trial Copy any sponsorship mentioned in the article (usually bottom left, first page)  
Methods    
Study design RCT, quasi‐RCT, non‐randomised CCT  
Method of randomisation Tables, coin, etc  
Allocation concealment Closed envelopes, etc  
Blindedness    
Population    
Place Hospital/City/Country  
Enrolment dates Helps in finding out double‐reported populations  
Inclusion criteria    
Exclusion criteria    
Age Describe the age of the included population  
Sex Describe the sex distribution of the included population  
Ethnicity    
Work status    
Duration of symptoms    
Previous treatments    
Total number of patients recruited    
Number of patients who met inclusion criteria    
Total number of patients randomised    
Total number of patients followed    
Interventions:    
Group 1
PCL (yes/no)
Brand implant (manufacterer)
Patella (yes/no)
Bearing (mobile/fixed/rotating)
Flexion space (how determined)
You may copy the description of the intervention here, or simply indicate on which page and in which paragraph it can be found PCL:
Brand:
Patella:
Flexion space:
Group 2 Idem PCL: CR
Brand:
Patella:
Flexion space:
Group 3 Idem PCL:
Brand:
Patella:
Flexion space:
Outcomes    
Who carried out the measurement?    
What were the follow‐up moments? Preop 6 Months 12 Months 24 Months ___Months
What was measured at each follow‐up and with which tool?
ROM
KSS functional
KSS clinical
VAS
WOMAC
KOOS
OKS
HSS
IKDC
Active flexion
Passive flexion
Revision
Mortality
SF‐36
Gait analysis
Good Samaritan Knee Assessment Questionnaire
         
Analysis:    
Statistical technique used: Which tests? Alpha? Power? Sample size calculation? Software used? Power:
Sample size:
Software:
Does technique adjust for confounding?    
Number (or %) followed‐up from each group:    
Results:    
Quantitative results If no between‐group comparisons are given, then report here the general results  
Qualitative results    
Adverse effects or complications    
1. Comparison: (A) .................. (N=) vs (B) .................... (N= )
Outcome:
Follow‐up: preop (A): 0 (0) (B): 0 (0)
6 months (A): 0 (0) (B): 0 (0)
12 months (A): 0 (0) (B): 0 (0)
24 months (A): 0 (0) (B): 0 (0)
X months (A): 0 (0) (B): 0 (0)
2. Comparison: (A) .................. (N=) vs (B) .................... (N= )
Outcome:
Follow‐up: preop (A): 0 (0) (B): 0 (0)
6 months (A): 0 (0) (B): 0 (0)
12 months (A): 0 (0) (B): 0 (0)
24 months (A): 0 (0) (B): 0 (0)
X months (A): 0 (0) (B): 0 (0)
3. Comparison: (A) .................. (N=) vs (B) .................... (N= )
Outcome:
Follow‐up: preop (A): 0 (0) (B): 0 (0)
6 months (A): 0 (0) (B): 0 (0)
12 months (A): 0 (0) (B): 0 (0)
24 months (A): 0 (0) (B): 0 (0)
X months (A): 0 (0) (B): 0 (0)
4. Comparison: (A) .................. (N=) vs (B) .................... (N= )
Outcome:
Follow‐up: preop (A): 0 (0) (B): 0 (0)
6 months (A): 0 (0) (B): 0 (0)
12 months (A): 0 (0) (B): 0 (0)
24 months (A): 0 (0) (B): 0 (0)
X months (A): 0 (0) (B): 0 (0)